Source:http://linkedlifedata.com/resource/pubmed/id/21547512
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2011-5-10
|
pubmed:abstractText |
Glucagon-like peptide-1 (GLP-1) is secreted from the L cell of the gut in response to oral nutrient delivery. To determine if endogenously released GLP-1 contributes to the incretin effect and postprandial glucose regulation, conscious dogs (n = 8) underwent an acclimation period (t = -60 to -20 min), followed by a basal sampling period (t = -20 to 0 min) and an experimental period (t = 0-320 min). At the beginning of the experimental period, t = 0 min, a peripheral infusion of either saline or GLP-1 receptor (GLP-1R) antagonist, exendin (9-39) (Ex-9, 500 pmol/kg/min), was started. At t = 30 min, animals consumed a liquid mixed meal, spiked with acetaminophen. All animals were studied twice (± Ex-9) in random fashion, and the experiments were separated by a 1-2-week washout period. Antagonism of the GLP-1R did not have an effect, as indicated by repeated-measures MANOVA analysis of the ? AUC from t = 45-320 min of arterial plasma glucose, GLP-1, insulin, glucagon, and acetaminophen levels. Therefore, endogenous GLP-1 is not sufficient to alter postprandial glucose regulation in the dog.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetaminophen,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Glucagon,
http://linkedlifedata.com/resource/pubmed/chemical/Glucagon-Like Peptide 1,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Glucagon,
http://linkedlifedata.com/resource/pubmed/chemical/exendin (9-39),
http://linkedlifedata.com/resource/pubmed/chemical/glucagon-like peptide receptor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1559-0100
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
229-34
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:21547512-Acetaminophen,
pubmed-meshheading:21547512-Animals,
pubmed-meshheading:21547512-Blood Glucose,
pubmed-meshheading:21547512-Dogs,
pubmed-meshheading:21547512-Enteroendocrine Cells,
pubmed-meshheading:21547512-Female,
pubmed-meshheading:21547512-Food,
pubmed-meshheading:21547512-Gastric Emptying,
pubmed-meshheading:21547512-Glucagon,
pubmed-meshheading:21547512-Glucagon-Like Peptide 1,
pubmed-meshheading:21547512-Homeostasis,
pubmed-meshheading:21547512-Insulin,
pubmed-meshheading:21547512-Kinetics,
pubmed-meshheading:21547512-Male,
pubmed-meshheading:21547512-Peptide Fragments,
pubmed-meshheading:21547512-Receptors, Glucagon
|
pubmed:year |
2011
|
pubmed:articleTitle |
Endogenously released GLP-1 is not sufficient to alter postprandial glucose regulation in the dog.
|
pubmed:affiliation |
Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. johnsonkms@beloit.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|